Bengaluru AI medtech Tricog scales global footprint; partners with Sanofi, OMRON to hit 100-m patient goal
Bengaluru, Oct 22 (TNT) : Bengaluru-based cardiovascular AI company Tricog Health on Thursday announced the scaling of its international operations backed by strategic global alliances with French pharmaceutical major Sanofi and Japan’s OMRON Healthcare, aiming to bring connected cardiac care to 100 million people by 2030.
Founded in 2014 by interventional cardiologist Dr. Charit Bhograj, Tricog began as a remote ECG diagnosis platform designed to solve acute delays in cardiac interpretation in regions lacking specialist doctors.
Over the past 12 years, the company has scaled across India, Southeast Asia, and Africa, screening over 40 million patients and claiming to have helped save more than one million lives.
The company’s cross-border push gained momentum in September 2026 through a three-year strategic collaboration signed with Sanofi as part of the bilateral India-France Year of Innovation under the Bharat Innovates framework.
The partnership opens international market channels and explores potential joint business and investment opportunities across emerging economies.
Simultaneously, Tricog is deepening its long-term partnership with OMRON Healthcare to integrate diagnostic screening with continuous post-discharge monitoring, aligning with OMRON’s “Going for ZERO” cardiovascular prevention initiative.
Through Tricog’s remote patient management platform KeeboHealth and its single-lead AI screening tool Tricog CardioCheck, the two entities are deploying home-monitoring ecosystems that alert clinicians to subtle physiological shifts before adverse cardiac events occur.
The validation of Tricog’s AI diagnostics was further bolstered in May 2026 following a peer-reviewed study published in JAMA Cardiology.
Conducted in Kenya alongside the Kenya Cardiac Society, the study demonstrated that routine ECGs interpreted via Tricog’s AI models could reliably flag patients with weakened heart pump function (left ventricular dysfunction)—a condition that conventionally demands an expensive, hospital-based echocardiogram.
“When we started Tricog, we were trying to solve a very specific problem: an ECG could be taken in minutes, but if no one was available to read it in time, the delay could prove fatal,” said Dr. Charit Bhograj, CEO and Founder of Tricog Health.
“Today, our ambitions are much larger. We want to identify cardiac risks earlier across the spectrum, support patients post-discharge, and make quality cardiac care available in underserved regions. Having organisations like Sanofi and OMRON Healthcare associated with our journey gives us the reach and capabilities to scale faster.”
With global cardiovascular diseases claiming upwards of 20 million lives annually—disproportionately impacting the Global South due to infrastructure and specialist deficits—Tricog said it is focusing on integrating its core portfolio, including InstaECG and InstaEcho, into broader public healthcare networks to reach its 2030 target.
TNT KS
